|
|||||
|
|
Refining immunotherapeutic approaches to high‐risk neuroblastoma based on tumor genomic profiles |
|
| Authors: | Liron D. Grossmann John M. Maris |
| Affiliation: | 1. Department of Pediatrics and Center for Childhood Cancer Research, The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, USA |
| Abstract: | |
| Keywords: | 11q deletion, anti‐ GD2 therapy, immune checkpoint inhibition, microRNAs |